![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
Departments of 3 Nutritional Sciences and 4 Pathobiology and Veterinary Science, University of Connecticut, Storrs, CT 06269-4017
* To whom correspondence should be addressed. E-mail: richard.bruno{at}uconn.edu.
The incidence of nonalcoholic fatty liver disease (NAFLD) has risen along with the ongoing obesity epidemic. Green tea extract (GTE) inhibits intestinal lipid absorption and may regulate hepatic lipid accumulation. The objective of this study was to determine whether GTE protects against hepatic lipid accumulation during the development of NAFLD in an obese mouse model. Five-wk-old ob/ob (obese) mice and their lean littermates (8 mice·genotype–1·dietary treatment–1) were fed GTE at 0, 1, or 2% (wt:wt) for 6 wk. The body weights of obese mice and lean littermates fed diets containing GTE were 23–25% and 11–20% lower (P < 0.05) than their respective controls fed no GTE. Histologic evaluation showed a significant reduction in hepatic steatosis in GTE-fed obese mice only and histologic scores were correlated with hepatic lipid concentration (r = 0.84; P < 0.05), which was reduced dose dependently by GTE. GTE protected against hepatic injury as suggested by 30–41% and 22–33% lower serum alanine aminotransferase and aspartate aminotransferase activities, respectively. Hepatic 
-tocopherol was 36% higher in obese mice than lean mice. GTE tended (P = 0.06) to lower hepatic -tocopherol, which was not fully explained by the GTE-mediated reduction in hepatic lipid. Hepatic ascorbic acid was lower in obese mice than in lean mice (P < 0.05) and was unaltered by GTE. Obese mice had lower serum adiponectin than lean mice and this was not affected by GTE. The results suggest that GTE protects against NAFLD by limiting hepatic lipid accumulation and injury without affecting hepatic antioxidant status and adiponectin-mediated lipid metabolism. Further study is underway to define the events by which GTE protects against obesity-triggered NAFLD.
This article has been cited by other articles:
|
|
 |
|
  U. T. Iwaniec, R. T. Turner, S. I. Koo, R. Kaur, E. Ho, C. P. Wong, and R. S. Bruno Consumption of Green Tea Extract Results in Osteopenia in Growing Male Mice J. Nutr., October 1, 2009; 139(10): 1914 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shrestha, S. J. Ehlers, J.-Y. Lee, M.-L. Fernandez, and S. I. Koo Dietary Green Tea Extract Lowers Plasma and Hepatic Triglycerides and Decreases the Expression of Sterol Regulatory Element-Binding Protein-1c mRNA and Its Responsive Genes in Fructose-Fed, Ovariectomized Rats J. Nutr., April 1, 2009; 139(4): 640 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frank, T. W. George, J. K. Lodge, A. M. Rodriguez-Mateos, J. P. E. Spencer, A. M. Minihane, and G. Rimbach Daily Consumption of an Aqueous Green Tea Extract Supplement Does Not Impair Liver Function or Alter Cardiovascular Disease Risk Biomarkers in Healthy Men J. Nutr., January 1, 2009; 139(1): 58 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Kim, R. Rajaiah, Q.-L. Wu, S. R. Satpute, M. T. Tan, J. E. Simon, B. M. Berman, and K. D. Moudgil Green Tea Protects Rats against Autoimmune Arthritis by Modulating Disease-Related Immune Events J. Nutr., November 1, 2008; 138(11): 2111 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bose, J. D. Lambert, J. Ju, K. R. Reuhl, S. A. Shapses, and C. S. Yang The Major Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat-Fed Mice J. Nutr., September 1, 2008; 138(9): 1677 - 1683. [Abstract] [Full Text] [PDF]
|
|
